Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2723-2730
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2723
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2723
Table 2 Pathological characteristics of patients (n = 83) n (%)
| Type II(n = 62) | Type III(n = 21) | P value | |
| T category | 0.06 | ||
| T1b | 11 (18) | 0 (0) | |
| T2 | 11 (18) | 2 (10) | |
| T3 | 40 (64) | 19 (90) | |
| N category | 0.41 | ||
| N0 | 21 (34) | 4 (19) | |
| N1 | 12 (19) | 6 (29) | |
| N2 | 13 (21) | 3 (14) | |
| N3 | 14 (23) | 6 (29) | |
| LNR | 0.063 (0-1) | 0.047 (0-0.41) | 0.74 |
| M category | 0.64 | ||
| M0 | 58 (94) | 19 (90) | |
| M1 | 4 (6) | 2 (10) | |
| TNM stage | 0.30 | ||
| IA | 10 (16) | 0 (0) | |
| IB | 5 (8) | 0 (0) | |
| IIA | 6 (10) | 4 (19) | |
| IIB | 5 (8) | 1 (5) | |
| IIIA | 8 (13) | 5 (24) | |
| IIIB | 11 (18) | 3 (14) | |
| IIIC | 12 (19) | 6 (29) | |
| IV | 5 (8) | 2 (10) | |
| ly category | 0.35 | ||
| ly0 | 8 (13) | 0 (0) | |
| ly1 | 16 (26) | 5 (24) | |
| ly2 | 22 (35) | 9 (43) | |
| ly3 | 16 (26) | 7 (33) | |
| v category | 0.55 | ||
| v0 | 7 (11) | 3 (14) | |
| v1 | 13 (21) | 4 (19) | |
| v2 | 24 (39) | 5 (24) | |
| v3 | 18 (29) | 9 (43) | |
| Histopathological grade | 0.56 | ||
| G1 + G2 | 37 (60) | 11 (52) | |
| G3 + G4 | 25 (40) | 10 (48) |
- Citation: Hosoda K, Yamashita K, Moriya H, Mieno H, Watanabe M. Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up. World J Gastroenterol 2017; 23(15): 2723-2730
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2723.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2723